Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group.

PubWeight™: 3.41‹?› | Rank: Top 1%

🔗 View Article (PMID 2651003)

Published in Crit Care Med on May 01, 1989

Authors

R C Bone1, C J Fisher, T P Clemmer, G J Slotman, C A Metz, R A Balk

Author Affiliations

1: Department of Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612.

Articles citing this

Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg (1992) 4.50

The enigma of sepsis. J Clin Invest (2003) 4.32

Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest (1991) 3.62

Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli. J Clin Invest (1991) 2.17

MCP-1 protects mice in lethal endotoxemia. J Clin Invest (1997) 2.12

New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev (2012) 2.01

Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Intensive Care Med (2010) 2.00

Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ (1993) 1.65

Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury. Crit Care (2010) 1.56

Gram-negative sepsis: a dilemma of modern medicine. Clin Microbiol Rev (1993) 1.55

Comparison of trends in sepsis incidence and coding using administrative claims versus objective clinical data. Clin Infect Dis (2014) 1.51

Loss of upper respiratory tract immunity with parenteral feeding. Ann Surg (1996) 1.47

Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial. BMJ (2015) 1.46

Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality. Infect Immun (1997) 1.39

Physiological-dose steroid therapy in sepsis [ISRCTN36253388]. Crit Care (2002) 1.24

Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg (1991) 1.12

Elevated calcitonin precursor levels are related to mortality in an animal model of sepsis. Crit Care (1999) 1.11

Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today? Virulence (2013) 1.10

DNA fragmentation in mouse organs during endotoxic shock. Am J Pathol (1996) 1.10

Febrile-range temperature modifies early systemic tumor necrosis factor alpha expression in mice challenged with bacterial endotoxin. Infect Immun (1999) 1.09

Animal models of Streptococcus pneumoniae disease. Clin Microbiol Rev (2008) 1.07

Rapid diagnosis of sepsis. Virulence (2013) 1.06

Clinical utility of biomarkers of endothelial activation in sepsis--a systematic review. Crit Care (2012) 1.04

Anti-lipoteichoic acid antibodies enhance release of cytokines by monocytes sensitized with lipoteichoic acid. Infect Immun (1994) 1.04

Prognostic factors for survival in colonic perforation. Int J Colorectal Dis (1994) 1.02

Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbits. Infect Immun (1993) 1.01

The birth pangs of monoclonal antibody therapeutics: the failure and legacy of Centoxin. MAbs (2012) 1.00

Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice. Immunology (1999) 0.99

The Japanese guidelines for the management of sepsis. J Intensive Care (2014) 0.99

High Output Cardiac Failure. Curr Treat Options Cardiovasc Med (2001) 0.98

Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study. Crit Care (2005) 0.95

Influence of insulin on glucose metabolism and energy expenditure in septic patients. Crit Care (2004) 0.93

Phospholipase A2 from plasma of patients with septic shock is associated with high-density lipoproteins and C3 anaphylatoxin: some implications for its functional role. Biochem J (1995) 0.90

Sepsis in the pediatric cardiac intensive care unit. World J Pediatr Congenit Heart Surg (2011) 0.90

Liver histology in ICU patients dying from sepsis: a clinico-pathological study. World J Gastroenterol (2008) 0.90

Identifying Patients with Sepsis on the Hospital Wards. Chest (2016) 0.90

Diphosphoryl lipid A from Rhodobacter sphaeroides inhibits complexes that form in vitro between lipopolysaccharide (LPS)-binding protein, soluble CD14, and spectrally pure LPS. Infect Immun (1997) 0.88

Toward an operative diagnosis in sepsis: a latent class approach. BMC Infect Dis (2008) 0.88

Nitric oxide production in critically ill patients. Arch Dis Child (1996) 0.88

Experience with prolonged induced hypothermia in severe head injury. Crit Care (1999) 0.87

Cefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndrome. Antimicrob Agents Chemother (1994) 0.86

Monoclonal antibodies to endotoxin in the management of sepsis. West J Med (1993) 0.84

Sepsis: From Pathophysiology to Individualized Patient Care. J Immunol Res (2015) 0.83

Sequential anti-core glycolipid immunoglobulin antibody activities in patients with and without septic shock and their relation to outcome. Ann Surg (1993) 0.82

High medical impact of implementing the new polymeric bead-based BacT/ALERT® FAPlus and FNPlus blood culture bottles in standard care. Eur J Clin Microbiol Infect Dis (2015) 0.82

Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis. Eur J Clin Microbiol Infect Dis (2003) 0.81

Procalcitonin is a marker of gram-negative bacteremia in patients with sepsis. Am J Med Sci (2015) 0.80

Bench-to-bedside review: ventilatory abnormalities in sepsis. Crit Care (2009) 0.79

A prospective treatment for sepsis. Drug Des Devel Ther (2015) 0.79

Sepsis progression and outcome: a dynamical model. Theor Biol Med Model (2006) 0.78

Severity scoring systems for prognosis and efficacy of polymyxin B-immobilized fiber treatment for colonic perforation. Surg Today (2006) 0.78

Febrile response induced by cecal ligation and puncture (CLP) in rats: involvement of prostaglandin E2 and cytokines. Med Microbiol Immunol (2011) 0.78

Prevalence of occult adrenal insufficiency and the prognostic value of a short corticotropin stimulation test in patients with septic shock. Indian J Crit Care Med (2009) 0.78

Leptin fails to blunt the lipopolysaccharide-induced activation of the hypothalamic-pituitary-adrenal axis in rats. J Endocrinol (2014) 0.78

Meropenem versus cefuroxime plus gentamicin for treatment of serious infections in elderly patients. Antimicrob Agents Chemother (1998) 0.76

Nonpharmacologic approach to minimizing shivering during surface cooling: a proof of principle study. J Crit Care (2012) 0.76

The pulmonary physician and critical care. 3. Pharmacotherapy in lung injury. Thorax (1992) 0.75

Refractory septic shock in children: a European Society of Paediatric and Neonatal Intensive Care definition. Intensive Care Med (2016) 0.75

Early PREdiction of Severe Sepsis (ExPRES-Sepsis) study: protocol for an observational derivation study to discover potential leucocyte cell surface biomarkers. BMJ Open (2016) 0.75

Intensive care. Postgrad Med J (1993) 0.75

Introduction to Pediatric Sepsis. Open Inflamm J (2011) 0.75

Unopposed interleukin-1 is necessary for increased plasma cytokine and eicosanoid levels to develop in severe sepsis. Ann Surg (1997) 0.75

Sepsis: Diagnostic and Therapeutic Challenges. Biomed Res Int (2016) 0.75

Severe sepsis: Low expression of the renin-angiotensin system is associated with poor prognosis. Exp Ther Med (2014) 0.75

A model for rational introduction of new and expensive medicines. Postgrad Med J (1995) 0.75

Monoclonal antibodies in sepsis and septic shock. BMJ (1992) 0.75

Equivocal definitions of sepsis and septic shock. Crit Care Med (1990) 0.75

Gene expression pattern in human monocytes as a surrogate marker for systemic inflammatory response syndrome (SIRS). Mol Med (1999) 0.75

Patient cytokine response in transfusion-associated sepsis. Infect Immun (1994) 0.75

The gastrointestinal immune system: Implications for the surgical patient. Curr Probl Surg (2015) 0.75

Diagnosing sepsis: a step forward, and possibly a step back. Ann Transl Med (2017) 0.75

Treatment of sepsis in an intensive care unit. Intensive Care Med (1990) 0.75

Procalcitonin - Assisted Antibiotic Strategy in Sepsis. EJIFCC (2017) 0.75

Diagnosis of bacterial infection in the ICU: general principles. Intensive Care Med (1994) 0.75

Articles by these authors

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest (1992) 47.46

Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med (2001) 27.70

A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med (1998) 14.59

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med (1991) 9.99

Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med (1994) 5.80

Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med (1993) 5.46

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med (1996) 5.25

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA (1994) 5.24

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med (1997) 4.86

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med (1987) 3.89

Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med (1995) 3.74

The relation of pneumothorax and other air leaks to mortality in the acute respiratory distress syndrome. N Engl J Med (1998) 3.40

Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J Cell Sci (1992) 3.18

Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med (1992) 2.99

Sepsis: a new hypothesis for pathogenesis of the disease process. Chest (1997) 2.84

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit Care Med (1994) 2.66

A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med (1995) 2.48

High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med (1987) 2.32

Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis? Hum Pathol (1993) 2.27

E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators. JAMA (2000) 2.07

Twenty-four-hour intragastric pH patterns in ICU patients on ranitidine. Dig Dis Sci (1992) 2.04

The adult respiratory distress syndrome. A report of survival and modifying factors. Chest (1992) 2.00

Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. The Ibuprofen Study Group. Crit Care Med (1991) 1.83

Regionalization of critical care medicine: task force report of the American College of Critical Care Medicine. Crit Care Med (1994) 1.76

Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med (2000) 1.70

Complications of pulmonary artery catheterization in the care of critically ill patients. A prospective study. Chest (1979) 1.68

Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis (1988) 1.65

Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. JAMA (1994) 1.64

A strategy for development of computerized critical care decision support systems. Int J Clin Monit Comput (1992) 1.55

New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet (1997) 1.55

Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med (1991) 1.53

Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am Rev Respir Dis (1990) 1.46

Physician decision-making--evaluation of data used in a computerized ICU. Int J Clin Monit Comput (1984) 1.44

Medical effectiveness of esophageal balloon pressure manometry in weaning patients from mechanical ventilation. Crit Care Med (1995) 1.43

Effect of advance directives on the management of elderly critically ill patients. Crit Care Med (1998) 1.43

Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest (1987) 1.43

Sleep apnea and the Arnold-Chiari malformation. Am Rev Respir Dis (1985) 1.42

Descriptive analysis of critical care units in the United States. Crit Care Med (1992) 1.41

Severe recalcitrant erythematous desquamating disorder associated with fatal recurrent toxic shock syndrome in a patient without AIDS. Clin Infect Dis (1997) 1.40

Prognostic factors in sepsis: the cold facts. Crit Care Med (1992) 1.40

Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock. Crit Care Med (1999) 1.39

p53 represses androgen-induced transactivation of prostate-specific antigen by disrupting hAR amino- to carboxyl-terminal interaction. J Biol Chem (2001) 1.30

The Rapid Acute Physiology Score. Am J Emerg Med (1987) 1.24

Clinical performance of a rule-based decision support system for mechanical ventilation of ARDS patients. Proc Annu Symp Comput Appl Med Care (1993) 1.23

A successful computerized protocol for clinical management of pressure control inverse ratio ventilation in ARDS patients. Chest (1992) 1.17

The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysis. JAMA (1993) 1.14

Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10. Clin Immunol Immunopathol (1996) 1.10

c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation. Oncogene (2006) 1.09

Staphylococcus epidermidis sepsis in surgical patients. Arch Surg (1984) 1.08

Increased survival of ARDS patients with severe hypoxemia (ECMO criteria). Chest (1991) 1.08

Enterococcal bacteremia in surgical patients. Arch Surg (1985) 1.07

Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial. Arch Surg (1994) 1.06

Relative concentrations of endotoxin-binding proteins in body fluids during infection. Lancet (1994) 1.05

Fungal sepsis in surgical patients. Arch Surg (1983) 1.04

Comparison between p53 staining in tissue sections and p53 proteins levels measured by an ELISA technique. Br J Cancer (1993) 1.04

Effect of ranitidine on intragastric pH and stress-related upper gastrointestinal bleeding in patients with severe head injury. Dig Dis Sci (1995) 1.04

Enterobacter bacteremia in surgical patients. Surgery (1986) 1.03

Pneumothorax detection using computerised analysis of breath sounds. Med Biol Eng Comput (2002) 1.03

Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis. The rhIL-1ra Phase III Sepsis Syndrome Study Group. Crit Care Med (1996) 1.02

Pneumothorax detection using pulmonary acoustic transmission measurements. Med Biol Eng Comput (2002) 1.00

Ketoconazole prevents Candida sepsis in critically ill surgical patients. Arch Surg (1987) 1.00

Indwelling small pleural catheter needle thoracentesis in the management of large pleural effusions. Chest (1997) 0.99

The clinical spectrum of toxic shock syndrome. West J Med (1981) 0.98

Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome. Effects of cyclooxygenase inhibition. Am Rev Respir Dis (1991) 0.98

Outcome of critically injured patients treated at Level I trauma centers versus full-service community hospitals. Crit Care Med (1985) 0.97

Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine (2000) 0.97

Nutritional support in the adult respiratory distress syndrome. Clin Chest Med (1982) 0.96

A survey of advanced trauma life support procedures being performed by physicians and nurses used on hospital aeromedical evacuation services. Aviat Space Environ Med (1985) 0.96

The risk of infection related to radial vs femoral sites for arterial catheterization. Crit Care Med (1983) 0.95

Increased mortality of older patients with acute respiratory distress syndrome. Chest (1997) 0.95

Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension. Surgery (1986) 0.94

Comparison of the herpesviruses of cattle by DNA restriction endonuclease analysis and serologic analysis. Am J Vet Res (1985) 0.94

Telemedicine protocols and standards: development and implementation. J Med Syst (1995) 0.93

Impact of prospective payments on a tertiary care center receiving large numbers of critically ill patients by aeromedical transport. Crit Care Med (1986) 0.93

Calf-thigh sequential pneumatic compression compared with plantar venous pneumatic compression to prevent deep-vein thrombosis after non-lower extremity trauma. J Trauma (1999) 0.92

The economic impact of DRG payment policies on air-evacuated trauma patients. J Trauma (1988) 0.92

Fibrous dysplasia of the axis. A case report. Spine (Phila Pa 1976) (1989) 0.91

A decision support tool for antibiotic therapy. Proc Annu Symp Comput Appl Med Care (1995) 0.90

Head and neck cancer in a young age group: high incidence in black patients. Head Neck Surg (1983) 0.90

Septic endocarditis and indwelling pulmonary artery catheters. JAMA (1975) 0.89

Commitment to trauma in a low population density area. J Trauma (1981) 0.89

The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis. J Rheumatol (1995) 0.89

Prostaglandins, cyclo-oxygenase inhibitors, and thromboxane synthetase inhibitors in the pathogenesis of multiple systems organ failure. Crit Care Clin (1989) 0.88

Alteration of postischemic renal pathology by prostaglandin infusion. J Surg Res (1980) 0.88

Intrathecal sodium diatrizoate. Report of a case complicated by acute renal failure and review of the literature. Neurology (1966) 0.88

c-Jun potentiates the functional interaction between the amino and carboxyl termini of the androgen receptor. J Biol Chem (2001) 0.87

Nitric oxide in the pathogenesis of sepsis. Infect Dis Clin North Am (1999) 0.87